Removal of MAP4 from microtubules in vivo produces no observable phenotype at the cellular level by unknown
Removal of MAP4 from Microtubules In Vivo Produces No Observable 
Phenotype at the Cellular Level 
Xiao Min Wang,* John G. Peloquin,* Ye Zhai,* J. Chloe Bulinski,  ~ and Gary G. Borisy* 
*Laboratory of Molecular Biology, University of Wisconsin-Madison,  Madison, Wisconsin 53706; and~Department of Anatomy 
and Cell Biology, Columbia University College of Physicians and Surgeons, New York 10032 
Abstract. Microtubule-associated protein 4 (MAP4) 
promotes MT assembly in vitro and is localized along 
MTs in vivo. These results and the fact that MAP4 is 
the major MAP in nonneuronal cells suggest that 
MAP4's normal functions may include the stabilization 
of MTs in situ. To understand MAP4 function in vivo, 
we produced a blocking antibody (Ab) to prevent 
MAP4 binding to MTs. The COOH-terminal MT bind- 
ing domain of MAP4 was expressed in Escherichia coli 
as a glutathione transferase fusion protein and was in- 
jected into rabbits to produce an antiserum that was 
then affinity  purified and shown to be monospecific for 
MAP4. This Ab blocked >95% of MAP4 binding to 
MTs in an in vitro assay. Microinjection of the affinity 
purified Ab into human fibroblasts and monkey epithe- 
lial cells abolished MAP4 binding to MTs as assayed 
with a rat polyclonal antibody against the NH2-terminal 
projection domain of MAP4. The removal of MAP4 
from MTs was accompanied by its sequestration into 
visible MAP4-Ab immunocomplexes. However, the 
MT network appeared normal. Tubulin photoactiva- 
tion and nocodazole sensitivity assays indicated that 
MT dynamics were not altered detectably by the re- 
moval of MAP4 from the MTs. Cells progressed to mi- 
tosis with morphologically normal spindles in the ab- 
sence of MAP4 binding to MTs. Depleting MAP4 from 
MTs also did not affect the state of posttranslational 
modifications of tubulin subunits. Further, no perturba- 
tions of MT-dependent organelle distribution were de- 
tected. We conclude that the association of MAP4 with 
MTs is not essential for MT assembly or for the MT- 
based functions in cultured cells that we could assay. A 
significant role for MAP4 is not excluded by these re- 
suits, however, as MAP4 may be a component of a 
functionally  redundant system. 
T 
HE dynamic character of cytoplasmic  organization 
as  displayed  in  cell  locomotion,  the  interphase- 
mitosis transition, and the generation of asymmetric 
cell form prompts consideration of possible  mechanisms 
by which the lability and plasticity  of the underlying cy- 
toskeleton might be regulated. Regulation of the microtu- 
bule (MT) 1 component of the cytoskeleton, in particular 
warrants attention because of its central role in determin- 
ing cell polarity. 
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MTs have been demonstrated in vitro to exhibit stochas- 
tic alternation between phases of polymerization and de- 
polymerization,  a  behavior  termed  dynamic instability 
(Mitchison  and Kirschner, 1984). Similar behavior occurs 
in vivo (Soltys and Borisy,  1985; Schulze and Kirschner, 
1986; Sammak and Borisy, 1988; Cassimeris  et al., 1988), 
although in addition to cycles of growth and shrinking, 
MTs may also "pause" for some time. While dynamic in- 
stability is an intrinsic property of the MT, it is not suffi- 
cient to account for regulated changes in cytoskeletal or- 
ganization.  The  generation of cell  form would seem to 
require additional factors to spatially  or temporally alter 
MT dynamics. 
Microtubule-associated protein  4  (MAPs)  have  been 
shown  to promote MT polymerization and dampen MT 
dynamics in vitro (reviewed by Olmsted, 1991; Chapin and 
Bulinski,  1992; Hirokawa, 1994). Although the biochemi- 
cal properties of MAPs have been established for some 
time,  their  cellular  role  is  as  yet not  understood.  The 
MAPs originally isolated from brain have been shown to 
be specific to nervous tissue (MAP2 and tau) or abundant 
only in nervous tissue (MAPIA and MAP1B). In contrast, 
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cells (Bulinski and Borisy, 1979; Weatherbee et al., 1980) 
has been found in a wide variety of cell and tissue types 
(Bulinski  and  Borisy,  1980b).  Moreover,  MAP4  is  the 
principal  MAP  thus  far  characterized  in  proliferating 
mammalian cells. Cloning and sequencing of MAP4 (hu- 
man, Chapin and Bulinski, 1991; mouse, West et al., 1991; 
bovine, also called MAP-U, Aizawa et al., 1990) as well as 
the  neuron-specific MAP2  (Lewis et  al.,  1988)  and  tau 
(Lee et  al.,  1988)  have  revealed that  all  three  types of 
MAP  contain,  near  their  respective  COOH  termini,  a 
shared MT-binding domain containing three to five imper- 
fect repeats of an 18-amino acid motif, an adjacent pro-rich 
region also involved in MT binding and an NH2-terminal 
projection domain. Thus, MAP2, tau and MAP4 constitute 
a superfamily of MT-binding proteins (reviewed by Bulin- 
ski, 1994; Hirokawa, 1994; Matus, 1994). 
One  attractive hypothesis about the general function 
of MAPs is that they serve as stabilizers of MTs. Two lines 
of experimentation have been employed to test the effects of 
MAPs on MT stability in vivo. One has been to increase 
the cellular level of MAPs by either transfection or micro- 
injection of protein; the  other has been to diminish the 
level either by the antisense approach or gene targeting. 
Transfection of both MAP2 and tau into nonneuronal cells 
or microinjection of tau protein into fibroblasts resulted in 
enhanced  MT  stability  and  assembly  as  assayed  by  in- 
creased MT polymer number and nocodazole resistance 
(Drubin and Kirschner, 1986; Lewis et al.,  1989; Lee and 
Rook, 1992).  However, Barlow et al.  (1994) did not ob- 
serve that elevated levels of expression of tau or MAP4 in- 
creased the MT polymer ratio or stabilized MTs, except 
for the MT bundles induced by increased tau. The expla- 
nation for this discrepancy in results is not clear, although 
it could be due to different levels of MAP expression or to 
the use of different cell lines. The results of reductions in 
MAP2  or tau expression by use of antisense oligonucle- 
otides for tau  or MAP2 in cultured neuronal cells have 
suggested an essential role for these proteins in neurite ex- 
tension, a process requiring enhanced MT assembly (Ca- 
ceres and Kosik, 1990; Dinsmore and Solomon, 1991). Yet, 
a  null mutant  for tau  created by gene targeting yielded 
mice with no obvious functional defects although the num- 
ber  of MTs  was  slightly reduced in  small  caliber axons 
(Harada et al., 1994). These conflicting results leave the in 
vivo role of MAPs in MT assembly unresolved. 
MT dynamics increase about 20-fold when cells enter 
mitosis (Saxton et al., 1984). Further, the addition of matu- 
ration-promoting factor (MPF) or mitogen-activated pro- 
tein kinase (MAP kinase) to interphase Xenopus egg ex- 
tracts increased MT dynamics from interphase to mitotic 
levels (Verde et al., 1990; Belmont et al., 1990). MAP4 was 
found to be differentially phosphorylated at the onset of 
mitosis (Vandr6 et al., 1991) and in vitro phosphorylation 
of MAP4 by MPF reduced its MT assembly-promoting ac- 
tivity  (Aizawa  et  al.,  1991)  and  MT-stabilizing  ability 
(Ookata et al., 1995). Shiina et al. (1992) and Anderson et 
al. (1994) identified 220- and 230-kD MAPs in extracts of 
Xenopus eggs and suggested on the basis of thermostabil- 
ity and size that they may be related to MAP4. The phos- 
phorylation of these Xenopus MAPs  in mitosis reduced 
their affinity for MTs. Thus, it has been postulated that 
phosphorylation of MAP4 by mitotic kinase(s) reduces its 
binding affinity to MTs and modulates the transition from 
the interphase MT array to the mitotic spindle. This puta- 
tive reduction in MAP affinity for MTs in mitosis may be 
taken as another argument that MAPs in interphase serve 
to stabilize MTs. 
The level of MT dynamics in interphase may be consid- 
ered a constitutive level which can be regulated up or down. 
In contrast to the majority of spindle MTs, which are more 
dynamic than the average interphase MT, many cells con- 
tain  substantial  numbers  of less  dynamic MTs,  some  of 
which may survive most of the cell cycle (Schulze and Kirsch- 
ner, 1987; Webster et al., 1987). The less dynamic MTs are 
generally marked by posttranslational modifications of the 
ct-tubulin subunits, typically removal of the COOH-termi- 
nal tyrosine or acetylation of an e-amino group of Lys40 
(Gundersen et al.,  1987; Piperno et al.,  1987).  However, 
these modifications appear to be the consequence, not the 
cause,  of the  enhanced  stability  (Khawaja  et  al.,  1988; 
Webster et al., 1990).  Perhaps MAPs, by stabilizing MTs, 
may indirectly cause MTs to become posttranslationally 
modified.  Indeed,  acetylated MTs  which  correlate with 
stable  MTs  have  been  shown  to  increase  dramatically 
upon transfection with tau (Lee and Rook, 1992). Related 
hypotheses for MAP function include roles in regulating 
the stiffness of MTs and in controlling their spacing (Ma- 
tus, 1994). 
Another possibility for the role of MAPs is that these 
proteins serve to mediate MT interaction with other or- 
ganetles within the cell. For example, a MT-binding pro- 
tein isolated from Hela cells has been demonstrated to be 
involved in the interaction of endosomes with MTs (Pierre 
et al.,  1992,  1994). This  170-kD protein has been desig- 
nated a cytoplasmic linker protein (CLIP) and may be one 
member of a class of MT-interacting molecules. 
Because  MAP4  is  the predominant  MAP  of nonneu- 
ronal cells as well as an ubiquitous component of the MTs 
of proliferating and differentiating cells, it is likely to be 
important in a number of MT functions. Thus, to examine 
the in vivo role of MAP4, we generated a polyclonal Ab 
against the MT-binding domain of MAP4 in order to block 
MAP4 binding to MTs in the cell. With this cellular immu- 
nodepletion approach, we have tested whether removal of 
MAP4 altered the MT network, increased MT lability, re- 
duced posttranslational modification, affected mitotic pro- 
gression, or perturbed the distribution of Golgi and mito- 
chondria. 
Materials and Methods 
Expression  Plasmid Construction 
Constructs of MAP4 were  derived  from the four-repeat species desig- 
nated isoform III (Bulinski, 1994). The plasmid pGEX-MAP4-C was con- 
structed by inserting a  gel-purified 2.0-kb BglII-EcoR1  fragment of the 
full-length MAP4 isoform Hfbl (Chapin et al., 1995) into the BamH1 and 
EcoR1 sites in the multicloning site of pGEX-2T. The protein product of 
pGEX-MAP4-C (MAP4-C) is a fusion protein with glutathione S-trans- 
ferase (GST) attached to the NH2 terminus of the COOH-terminal por- 
tion of MAP4 from residue 798. The plasmid pGEX-MAP4-N was con- 
structed by inserting a  gel purified 2.4-kb SmaI-NaeI fragment of the 
plasmid H9454 into the Sma! site in the multicloning site of pGEX-3X. 
The protein product of pGEX-MAP4-N  (MAP4-N) is a  fusion protein 
with GST attached to the NH  2 terminus of an NH2-terminal portion of 
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chia coli strain 11051. 
Expression and Purification of  MAP4 Proteins 
100 ml overnight cultures of transformed cells were diluted to 1 1 in LB 
media supplemented with ampicillin (100 Ixg/ml) and shaken at 37°C for 
45 min. IPTG was added to 0.4 mM and the culture shaken at 22°C for 3 h. 
Cells were harvested by centrifugation (Sorval GSA rotor, 5,000 rpm, 10 min, 
4°C; Dupont Co., Newton, CT) and resuspended in 20 ml of PBS contain- 
ing 1 N NaC1, 50 mM EDTA, 1 mM PMSF, 10 txg/ml pepstatin A, 10 I~g/ 
ml aprotinin. The cells were lysed on ice using a sonicator (Branson Sonic 
Power, Inc., Danbury, CT), equipped with a mierotip, for 6× 1 rain at set- 
ting 5, and 1% Triton X-100 added before centrifugation (Sorval SS-34 ro- 
tor, 30,000 g, 40 rain, 4°C). The clarified cell extracts were recycled over a 
2 ml column of glutathione-Sepharose 4B (Pharmacia, Piscataway, N J) for 
4 h at 4°(:, The column was washed with 10 vol of PBS and fusion proteins 
eluted with 50 mM Tris, pH 8.0, containing 10 mM glutathione. The peak 
fractions were pooled and dialyzed against PBS at 4°C. The protein con- 
centration was determined by the method of Bradford (Bradford, 1976). It 
was not possible to usefully cleave the MAP4 fragments from the GST 
carrier  by  thrombin  digestion because  thrombin  multiply cleaved  the 
MAP4 domain. 
Antibody Production, Purification, 
and Characterization 
Bacterially produced GST-COOH-terminal fusion protein (MAP4-C) was 
used to immunize New Zealand white rabbits (1 mg per primary injection, 
0.5 mg for later boosts). The resulting polyclonal antiserum was affinity 
purified using purified COOH-terminal fusion protein coupled to Amino- 
Link Coupling Gel  (Pierce  Chemical Co., Rockford,  IL)  following the 
manufacturer's instructions.  After  affinity  purification,  the  antibodies 
were dialyzed against 130 mM KC1, 10 mM Na Pipes, pH 7.0, 1 mM MgCI2 
at 4°C, and then concentrated to 6 mg/ml by ultrafiltration using centri- 
con-30 and microcon centrifugal filters (Amicon Corp., Beverly, MA). Af- 
finity purified antibodies were tested for their specificity against human 
MAP4 by Western blotting. Total Hela extract was separated by 7.5% 
SDS-PAGE according to the method of Laemmli (1970), transferred to 
nitrocellulose (Towbin et al., 1979), and probed with the affinity-purified 
antibody against the  COOH-terminal binding domain of MAP4 (anti- 
MAP4-C) followed by affinity-purified peroxidase conjugated goat anti- 
rabbit IgG (Kirkegard & Perry Laboratory Inc., Gaithersburg, MD). An- 
tibodies against the NH2-terminal portion of MAP4 (anti-MAP4-N) were 
obtained by injecting bacterially expressed and purified GST-MAP4-NH2- 
terminal fusion protein into rats (150 ~g per primary injection; 100 I~g for 
later boosts). The antiserum was tested for MAP4 specificity as for anti- 
MAP4-C above. 
In Vitro MT Blocking Assay 
Pure  tubulin was prepared  from porcine  brain as previously described 
(Borisy et al., 1975; Vallee and Borisy, 1978). HeLa cell extracts were pre- 
pared by brief sonication of cells in PEM buffer (1t30 mM Pipes, tmM 
EGTA, 1 mM MgSO4, pH 6.9) followed by centrifugation at 150,000 g in a 
TLS-55 rotor (Beckman, Palo Alto, CA) for 20 min at 4°C. Affinity puri- 
fied antibodies (final concentration 0.6 mg/ml or 0.06 mg/ml) or preim- 
mune IgG (final concentration 0.6 mg/ml) were incubated with the HeLa 
extract (20 mg/ml) for 1 h at room temperature. After the reaction, tubu- 
lin was added (2 mg/ml) in the presence of 10 txg/ml taxol and 1 mM GTP 
and incubated at 37°C for 15 min to assemble MTs. Finally, the mixture 
was centrifuged through a cushion of PEM and 20% glycerol at 200,000 g 
in a TLA-100 rotor (Beckman Instruments, Palo Alto, CA) at 20°C for 15 
min. The MT pellet was resuspended in PEM  buffer containing 0.3 N 
NaCI and  10 I~g/ml taxol. The resuspended solution was spun through 
PEM buffer and 20% glycerol at 200,000 g in a TLA-100 rotor for 15 rain 
at 20°C. The supernatant was analyzed on SDS-polyacrylamide gels and 
subsequently electroblotted to nitrocellulose (Amersham Corp., Arlington 
Heights, IL). The blot was incubated with antibodies against the COOH- 
terminal MT-binding region of MAP4 (anti-MAP4-C) at 2 Ixg/ml and af- 
finity-purified peroxidase-conjugated goat anti-rabbit antibodies (Kirke- 
garrd &  Perry Laboratories Inc.)  diluted to  1:5,000.  Peroxidase-labeled 
antibodies  were  then  detected  by  incubation  of  blots  with  enhanced 
chemiluminescence (ECL) reagents (1 and 2) and exposure to Hyperfilm 
(Amersham Corp.). 
Quantification of the amount of blocking was done by running a paral- 
lel Western blot of different concentrations of total HeLa extract contain- 
ing known quantities of MAP4 and analyzing as above. The film image 
was scanned with a Personal Densitometer SI and MAP4 band intensities 
quantified using ImageQuanNT software (Molecular Dynamics, Sunny- 
vale, CA).The data for the standard curve of integrated intensity versus 
concentration of MAP4 was fit by linear regression analysis. 
Cell Culture and Microinjection 
Human foreskin fibroblasts, line 356 (provided by Dr. Robert DeMars, 
University of Wisconsin, Madison, WI)  and  monkey kidney epithelial 
cells, LLCMK2 (American Type Culture Collection, Rockville, MD) were 
grown in F-10 medium supplemented with 15 and 5% fetal bovine serum, 
respectively. For injection, ceils were plated onto coverslips with photo- 
etched locator grids (Bellco, Vineland, N J) and grown for at least 2 d. 
Micropipettes were  pulled on a  vertical pipette  puller  (Kopf Instru- 
ments, Tujunga, CA). The microinjection of Abs was carried out with a 
Narishige IM-200 microinjector (Greenvale, NY). The needle concentra- 
tion of microinjected immune and preimmune IgG was 6 mg/ml. For pho- 
toactivation studies, since the cells were on the microscope stage for sev- 
eral  hours, the temperature  was maintained at  37°C with  a  stage and 
objective lens heater during the period of the experiment. To prevent pH 
change, the cell medium was overlaid with mineral oil. 
Nocodazole Treatment 
Three different experiments were carried out in which cells were treated 
with nocodazole at different concentrations and for different lengths of 
time. (a) MT lability. To test the lability of MTsin the absence of MAP4, 
human 356 cells were injected with the affinity purified anti-MAP4-C Ab, 
and then incubated for 2 h; the cells were treated with nocodazole (0.4 Ixg/ 
ml) for 5 min, lysed, fixed, and immediately immunostained  with antitubu- 
lin. (b) MT regrowth. LLCMK2 cells were first injected with affinity puri- 
fied  anti-MAP4-C Ab and then incubated  at  37°C for  1  h  to  remove 
MAP4 from MTs. Nocodazole (4 p.g/ml) was added to the medium for 1.5 h 
(conditions sufficient to depolymerize all tyrosinated (Tyr), detyrosinated 
(Glu),  and acetylated MTs as verified by antitubulin immunostaining). 
Nocodazole containing medium was removed to allow MT regrowth for I h. 
The cells were then fixed and prepared for immunofluorescence. (c) Mi- 
totic  collection.  LLCMK2 cells injected  with the affinity purified  anti- 
MAP4-C were treated with nocodazole at 0.04 Ixg/ml for 14 h to collect 
mitotic cells, released from the nocodazole block for 20 min, and then 
fixed and prepared for immunofluorescence. 
Immunofluorescence 
For MAP4 staining, cells were fixed with glutaraldehyde followed by lysis 
with Triton X-100 detergent to avoid the loss of MAP4 from MTs which 
would result from detergent lysis before fixation (Schliwa et al., 1981). 
Briefly, cells were washed with PEM buffer at 37°C, immersed in 2% glu- 
taraldehyde  for  30  min, and  then placed  in  a  permeabilization  buffer 
(0.5%  Triton X-100 in PEM buffer) for  15 min. In the experiments in 
which interphase cells were treated with nocodazole, the cells were lysed 
with permeabilization buffer for 2 rain before fixation with 0.7 % glutaral- 
dehyde  for  20  min. After  fixation, ceils were  treated  with  NaBI-L  to 
quench the unreacted glutaraldehyde and blocked with 10% normal goat 
serum. Primary and secondary Ab incubations were at 37°C for 1 h. The 
primary antibodies included: NH2-terminal MAP4 rat polyclonal antiserum 
at  a  1:500  dilution; mouse monoclonal anti-13-tubulin antibody (Amer- 
sham Corp.) at a 1:500 dilution for MT staining in interphase cells; YL-1/2 
rat monoclonal anti-et-tubulin antibody at a 1:500 dilution in MT regrowth 
experiments; mouse monoclonal anti-detyrosinated tubulin antibody (un- 
diluted hybridoma cell supernatant; a gift of Dr. J. Wehland, Max-Planck- 
Institute for Biophysical Chemistry, Heidelberg, Germany), for detyrosi- 
nated tubulin staining; mouse monoclonal anti-acetylated tubulin antibody 
(a gift of Dr. G. Piperno, The Rockefeller University, New York, NY) at a 
1:5 dilution for acetylated tubulin staining. The secondary antibodies in- 
cluded: afffinity-purified rhodamine-labeled goat anti-rabbit IgG at a 1:100 
dilution to stain the injected anti-MAP4-C Ab; affinity-purified fluorescein- 
conjugated goat anti-rat at  1:50; afffinity-purified fluorescein-conjugated 
goat anti-mouse at 1:50 (Kirkegarrd & Perry Laboratories Inc.). 
Images were recorded using either a 100×, 1.3 NA, or a 40×, t.0 NA 
objective  on  an  inverted  microscope  (Zeiss)  equipped  with  a  cooled 
charge-coupled device CCD camera (Photometrics, Tucson, AZ). An Im- 
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image processing. 
Direct Visualization of  MTs, Chromosomes, 
Mitochondria, and Golgi 
For direct visualization of MTs, cells were injected with a mixture of 
X-rhodamine tubulin (0.6 mg/ml) and anti-MAP4-C IgG (4 mg/ml) fol- 
lowed by fixing and staining as described above. Chromosome staining 
was done with DAPI at 2 p~g/ml  for 30 min. 
For visualization of mitochondria, the cells were incubated for 10 min 
in a growth medium containing 10 p.g/ml  rhodamine 123, a fluorescent dye 
for selectively staining mitochondria in the living cell (Chen, 1989). For 
images of the Golgi apparatus in live cells, cells were incubated with the 
fluorescent lipid analog 6-(N-7-nitrobenz-2-oxa-l,3-diazol-4-yl)-ceramide 
(C6-NBD-ceramide); 1 p.g was dissolved in 850 Ixl EtOH, and 50 ~l was 
mixed with 10 ml F-10 medium containing 6.8 mg defatted BSA. 
Measurements  of  MT Turnover by Photoactivation 
Human 356 cells were injected with affinity purified anti-MAP4-C anti- 
bodies and placed at 37°C in a  CO2 incubator for 2 h.  A  mixture of 
X-rhodamine tubulin (15 p.M) to visualize all MTs and caged-fluorescein 
tubulin (120 ~.M) to visualize photoactivated MTs was then injected into 
the same cells. The cells were allowed to incorporate labeled tubulin sub- 
units into the MTs for at least 1 h before photoactivation and imaging. 
Photoactivation experiments were performed essentially as described by 
Zhai et al. (1995). 
Results 
MAP4 Antibody Production and Characterization 
We prepared affinity-purified polyclonal Abs against fusion 
proteins of GST and segments of human MAP4 containing 
either the COOH-terminal binding domain (MAP4-C) or 
the NH2-terminal projection domain (MAP4-N) expressed 
in E. coli. The MAP4-C binding domain included the MT- 
binding repeat region and the majority of the proline-rich 
region (Fig. 1 A) both of which have been demonstrated to 
significantly contribute to MAP4's binding to MTs (Aizawa 
et al., 1991). SDS-PAGE of the bacterially expressed and 
glutathione  affinity-purified  fusion  protein  (Fig.  1  B) 
shows a principal component of 70-kD apparent molecular 
weight  together with  species of lower molecular weight. 
The apparent molecular weight on SDS gels is higher than 
the predicted value (GST 27 kD and MAP4-C 34 kD) sim- 
ilar to the behavior of whole MAP4 which has a  sequence 
determined molecular weight of 125  kD  but  runs  at  210 
kD. The lower molecular weight bands in Fig. 1 B  proba- 
bly represent  degradation  fragments,  since  they  reacted 
specifically with  an  antibody previously characterized as 
specific for MAP4 (Bulinski and Borisy, 1980a). The puri- 
fied fusion protein was used as immunogen to produce an- 
tiserum in rabbits which was affinity-purified on MAP4-C. 
The  results of immunoblotting showed  that  the  affinity- 
purified antibody (anti-MAP4-C) was specific for MAP4; 
that is, it recognized a single band comigrating with MAP4 
at  an  apparent molecular weight of 210  kD  on  a  blot of 
HeLa total protein (Fig. 1 C). The expressed and purified 
MAP4-N  projection domain  fusion  protein  migrated  on 
SDS-PAGE  predominantly as a  single band  with  an  ap- 
parent molecular weight of 115 kD (Fig. 1 B), again larger 
than the predicted value (GST 27  kD  and MAP4-N 68.6 
kD). Antibody produced in rats against the MAP4-N pro- 
jection domain was specific for MAP4 as assessed by west- 
ern blotting of HeLa total protein (Fig. 1 C). 
Figure 1.  Expression of MAP4 domains and specificity of anti- 
MAP4 domain Abs. (.4) Schematic structure of the MAP4 mole- 
cule and the MAP4 fragments expressed as GST fusion proteins. 
Four assembly promoting (AP) repeat sequences of 18 residues 
are indicated by the vertical bars. The proline-rich region (Pro- 
rich) that  also  contributes  to  MT  binding  is  indicated  by  a 
hatched  box.  Repetitive motifs  of  14  residues (KDM) in  the 
amino-terminal domain are indicated by closely spaced vertical 
lines. The left arrow shows the COOH-terminal boundary of the 
NHa-terminal MAP4 domain expressed in the GST fusion pro- 
tein MAP4-N. The right arrow shows the NH2-terminal boundary 
of the COOH-terminal MAP4 domain expressed in the GST fu- 
sion protein MAP4-C. The bracketed lines below the arrows indi- 
cate the portion of the MAP4 sequence present in MAP4-N (N) 
and MAP4-C (C). (B) Characterization of bacterially expressed 
and affinity purified GST-MAP4 fusion proteins. Left two lanes 
show E. coli expressed glutathione affinity purified GST-MAP4 
proteins electrophoresed on a 10% SDS-polyacrylamide  gel and 
stained with Coomassie brilliant blue dye (CBB). Right two lanes 
show immunoblotting of E. coli  expressed glutathione affinity pu- 
rified GST-MAP4 proteins with a polyclonal antibody generated 
against  the  whole  MAP4  molecule  (et-MAP4; Bulinski  and 
Borisy,  1980a).  N,  MAP4-N;  C,  MAP4-C.  Molecular  weight 
markers are indicated at left. (C) Characterization of antibodies 
specific for  the  MAP4  binding and  projection domains. Total 
Hela extract was electrophoresed on 10%  SDS-polyacrylamide 
gel and stained with Coomassie brilliant blue (CBB). A Western 
blot of the total Hela cell extract was probed with affinity purified 
rabbit antibody to the MAP4 MT binding domain (anti-MAP4-C), 
and with rat antiserum raised against the MAP4 projection domain 
(anti-MAP4-N). The reactive bands were visualized with peroxi- 
dase-conjugated  secondary  antibodies  and  enhanced  chemi- 
luminescence (ECL) reagents. Molecular weight markers are in- 
dicated. 
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blocking of MAP4 binding to 
microtubules.  Western  blots 
showing inhibition of MAP4 
binding to MTs in HeLa ex- 
tracts. Extracts were pre-incu- 
bated  with pre-immune  IgG 
or anti-MAP4-C IgG. The fi- 
nal supernatant fraction from 
the blocking assay containing MAPs extracted from MTs with 0.3 N 
NaC1 was separated  by 7.5% SDS-PAGE,  electroblotted  to ni- 
trocellulose, and probed with anti-MAP4-C IgG and peroxidase 
conjugated  secondary  antibody  and  visualized  with  ECL  re- 
agents. PI (0.6), pre-immune IgG (0.6 mg/ml); a-MAP4-C (0.06), 
anti-MAP4-C IgG (0.06 mg/ml); ~-MAP4-C  (0.18), anti-MAP4-C 
IgG (0.18 mg/ml); a-MAP4-C (0.6), anti-MAP4-C IgG (0.6 mg/ 
ml). Molecular weight markers are indicated. 
The Ab against the Binding Domain Blocks MAP4 
Binding to MTs In Vitro 
To test whether the anti-MAP4-C Ab could block MAP4 
binding to MTs in vitro, we devised an assay to measure 
blockage  of MT  binding.  HeLa  cell  extracts  containing 
MAP4 were preincubated with varying concentrations of 
purified  anti-MAP4-C. Tubulin was then  added in  suffi- 
cient quantity to produce a great excess of MAP-binding 
sites  when  polymerization was  induced  with  taxol.  The 
MTs were sedimented through a glycerol cushion to sepa- 
rate  MAP4 bound to MTs  from free MAP4. We found 
that  MAP4-anti-MAP4-C complexes  sedimented  in  the 
absence  of MTs.  Therefore,  MT-bound  MAP4  was  ex- 
tracted from the MTs with 0.3 N NaC1 and separated from 
the MTs and MAP4-Ab complexes by sedimentation. The 
final  supernatants  were  analyzed for  MAP4  content  by 
Western blot. Anti-MAP4-C blocking of MAP4 binding to 
MTs was assayed as a decrease in MAP4 relative to a pre- 
immune  IgG control.  As  shown  in  Fig.  2,  the  level  of 
MAP4 bound to  MTs  decreased  to  nearly undetectable 
levels with increasing anti-MAP4-C IgG concentration. A 
quantitative assessment of the reduction of MAP4 binding 
(see  Materials  and  Methods)  demonstrated  that  MAP4 
binding to MTs was reduced by 85%  in the presence of 
0.06 mg/ml anti-MAP4-C Ab, 94%  with 0.18  mg/ml anti- 
body, and by 98% at an antibody concentration of 0.6 mg/ml. 
Removal of MAP4  from MTs by Ab Injection 
Similar to the results obtained previously for Abs against 
whole  MAP4  purified  from Hela  cells  by Bulinski  and 
Borisy (1980a), our anti-MAP4-C Ab showed strong cross- 
reactivity only with  MAP4 from humans  and  other pri- 
mates (data not shown). Therefore, we chose human 356 
cells  (primary  fibroblasts)  and  monkey  LLCMK2  cells 
(kidney epithelia)  for microinjection. Cells were injected 
with Ab at a needle concentration of 6 mg/ml and at a vol- 
ume estimated from previous studies in the laboratory to 
be 5-10%  of the cell volume. Assuming the same effec- 
tiveness of the  antibody in vivo as in vitro, the resulting 
concentration in the cells would approach levels sufficient 
for almost complete blocking of MAP4 binding to MTs. 
The cells were then incubated for various periods of time 
and prepared for immunolocalization of MAP4. Because it 
Figure 3.  Time course of removal of MAP4 from MTs in cells. 
Human 356 cells were injected with either preimmune IgG (6 mg/ 
ml) (A and B) or affinity-purified anti-MAP4-C IgG (6 mg/ml) 
(C-H). The control cell (A and B) was fixed 2 h after the injec- 
tion  of preimmune  IgG; The  cells injected  with  anti-MAP4-C 
were fixed: 1 h (C and D), 2 h (E and F and I and J), and 24 h (G 
and H) after injection. All cells were stained with rat anti-MAP4-N 
serum and with fluorescein-labeled goat anti-rat antibodies to re- 
veal the distribution of MAP4 (B, D, F, H, and/). The cell in I 
and J was also stained with rhodamine-labeled  goat anti-rabbit 
IgG to show the distribution of injected Ab. Phase micrographs, 
(A, C, E, and G). (G and H) Pair of cells, only one of which was 
injected with the anti-MAP4 C (arrows). Bars: (A-F) 20 I~m; (G 
and H) 15 i~m; (I and J) 10 v,m. 
was difficult to find cells several hours after injection due 
to  cell  movement, the  ceils  were  also labeled  with goat 
anti-rabbit  Abs to distinguish  injected cells from nonin- 
jected ones. This label also allowed us to assay the relative 
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in preimmune injected or uninjected cells (see below, Fig. 
3, A  and  B).  In  contrast,  anti-MAP4-C  stained  MTs  in 
fixed ceils very weakly (data not shown), perhaps because 
the MAP4-binding domain epitopic sites were not accessi- 
ble  when  associated with  MTs.  Since MAP4  binding  to 
MTs has been demonstrated to be highly dynamic in vivo 
(Olmsted, 1989), we reasoned that in live cells the injected 
Abs would have ample opportunity to interact with MAP4 
during its dissociation from MTs. After Ab injection, loss 
of MAP4 binding to MTs was a gradual process as could 
be seen by the changes in the distribution of MAP4 re- 
vealed with the antibody directed against the NH~-termi- 
nal projection domain of MAP4 (Fig. 3). At 1 h after the 
injection of anti-MAP4-C,  MAP4  was  only partially re- 
moved from MTs, and both MT staining and weak spots 
could be seen. By 2  h  after injection, MAP4 staining of 
MTs  was  not  detectable  and  bright  spots  were  seen 
throughout the cytoplasm. The injected anti-MAP4 visual- 
ized with anti-rabbit IgG staining (Fig. 3 J) was visible as 
bright spots superimposed on a diffuse distribution of Ab, 
suggesting  an  excess of Ab  in  the  cytoplasm. The anti- 
MAP4-C spots colocalized with the MAP4 spots (Fig. 3, I 
and J) indicating that the spots comprised an immunopre- 
cipitation  complex  of  MAP4  and  anti-MAP4-C.  With 
longer incubation, the MAP4 aggregates increased in size 
and after 24 h, only one or a few large MAP4 aggregates 
were present. MAP4 staining of MTs remained below de- 
tectable levels for more than 24 h  indicating that seques- 
tration of MAP4 by the antibody was essentially irrevers- 
ible.  Injection  of  pre-immune  IgG  did  not  affect  the 
normal distribution of MAP4 on the MTs indicating that 
the blocking effect was a specific property of anti-MAP4-C. 
Effects of  Removal of  MAP4 from MTs on In Vivo MT 
Assembly and Organization 
Previous evidence indicated that MAP4 promotes MT as- 
sembly in vitro (Bulinski and Borisy, 1980c; Aizawa et al., 
1991).  Therefore, we  tested  whether  cells injected with 
anti-MAP4-C  Abs  retained  the  normal  distribution  and 
density of the MT network. Remarkably, despite the fact 
that MAP4 staining of MTs was no longer detectable, anti- 
tubulin MT staining (Fig. 4 C) demonstrated that both the 
MT network and the density of MTs  appeared indistin- 
guishable from noninjected control cells (Fig. 4 A). The 
high magnification view of an anti-MAP4-C-injected cell 
shows no anti-MAP4 labeling of MTs (Fig. 4 F) although 
individual MTs are clearly resolved with anti-tubulin stain- 
ing (Fig. 4 E). The normal organization of MTs was main- 
tained for at least 24 h after the injection (not shown) de- 
spite the seemingly irreversible sequestration of MAP4 by 
Ab. No obvious changes were seen in the linearity, curva- 
ture or distribution of the MT network suggesting that no 
large modifications had occurred in either the stiffness of 
the MTs or in  their tendency to remain separate  rather 
than bundled under normal growth conditions. Retention 
of the MT network suggested that removal of MAP4 did 
not reduce MT assembly. 
To  examine  possible  changes  in  MT  stability  with 
greater sensitivity, we used the MT depolymerizing drug 
nocodazole under conditions designed to dramatize differ- 
Figure 4.  The microtubule  network appeared unaffected by re- 
moval of MAP4. Human 356 cells double immunofluorescently 
labeled for tubulin (A, C, and E) and MAP4 (B, D, and F). The 
uninjected  cell (A  and  B) shows colocalization of tubulin  and 
MAP4.  (C-F)  Cells  were  injected  with  affinity-purified  anti- 
MAP4-C  (6 mg/ml) and fixed 4 h later.  MAP4 localization on 
MTs is no longer detectable. Bars: (A-D) 20 p~m; (E and F) 10 p~m. 
ences in MT lability. One of a pair of sister cells was in- 
jected with  anti-MAP4-C  followed by nocodazole treat- 
ment previously shown to depolymerize about one half of 
the original MTs in the noninjected cells (data not shown). 
Sister cells were chosen as they yield a more accurate com- 
parison than cells randomly chosen from the general pop- 
ulation. As shown in the example in Fig. 5, no noticeable 
difference in  MT density was  observed between the  in- 
jected and noninjected sister cells. 
Since it is possible that MAP4 is involved in the forma- 
tion of the MT network, but is no longer needed once the 
array has formed, we tested the capacity of cells to regrow 
MTs after release from nocodazole treatment. We again 
took the approach of injecting one cell in a pair of sister 
cells with anti-MAP4-C Ab.  LLCMK2 ceils were treated 
with nocodazole at 4  ~g/ml for 1.5 h, under which condi- 
tions all the MTs were depolymerized (data not shown). 
Subsequently, the nocodazole was removed and the cells 
were reincubated for 1 h to allow regrowth of MTs. Fig. 5 
shows a representative pair of sister cells with similar mor- 
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rendered  hyper-labile  by  re- 
moval  of MAP4  and  can  re- 
grow in the absence of MAP4. 
Sister cells early in G1, as iden- 
tified by  a  residual midbody, 
were used to test lability of mi- 
crotubules  to  nocodazole- 
induced depolymerization and 
capacity  for  microtubule  re- 
growth.  One cell of each pair 
of sister cells was injected (ar- 
rows). (A-C)  Human  356  fl- 
broblast  injected  with  anti- 
MAP4-C Ab (6 mg/ml), and 2 h 
later treated with  nocodazole 
(0.4 I~g/ml) for 5 min to depo- 
lymerize about 50% of the MT 
polymer, followed by lysis and 
fixation and  staining by anti- 
tubulin  antibody  (B).  (D-F) 
LLCMK2  cell  injected  with 
anti-MAP4-C  and  2  h  later 
treated with nocodazole (4 I~g/ 
nil) for 1.5 h  to depolymerize 
all the MTs and then allowed 
to regrow MTs for 1 h in no- 
codazole-free  medium.  Fi- 
nally, the cell was lysed, fixed, 
and  stained  with  anti-tubulin 
antibody  (E).  Rhodamine- 
labeled goat  anti-rabbit anti- 
bodies were used to visualize the injected antibodies, confirming the identity of the injected cells (C and F). Since the cells were lysed 
first to remove the soluble tubulin in order to reduce the background, there is little diffuse fluorescence seen in the goat anti-rabbit IgG 
panels (C and F). Bars: 20 I~m (A-C); 15 ~m (D-F). 
phologies and MT distributions. This result indicates that 
MTs can regrow in the absence of detectable MAP4 binding. 
Finally, MT dynamics were evaluated using photoactiva- 
tion of injected caged fluorescein. The fluorescence dissi- 
pation  curves  showed  no  significant  difference  between 
the two cell populations, demonstrating quantitatively that 
MAP4 removal did not  alter MT turnover rates (Fig. 6). 
Thus,  three different assay procedures failed to  show  an 
effect of MAP4 removal on microtubule organization, as- 
sembly or stability. 
Posttranslational Modifications of Tubulin Are Not 
Affected by Removal of MAP4  from MTs 
We  also  tested  the  role  of MAP4  in  MT  dynamics  and 
function by examining the subset of stable MTs marked by 
posttranslational  modifications  in  MAP4-depleted  and 
control cells. MAP4 could be involved in the acquisition of 
those modifications either directly or indirectly. A  direct 
involvement would suggest that MAP4 participated in the 
posttranslational  modification  system.  An  indirect  in- 
volvement might result from a  stabilizing effect of MAP4 
on  MTs,  since posttranslational modifications have  been 
demonstrated to be a  consequence rather than a  cause of 
stability (Khawaja et al., 1988; Webster et  al., 1990).  Al- 
though in our previous experiments the MT array was not 
altered by blocking of MAP4 binding to MTs, a MT subset 
might have been altered. 
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Figure 6.  Microtubule turnover is not measurably altered by re- 
moval of MAP4. Cells were injected with anti-MAP4-C and incu- 
bated for 2 h to allow removal of MAP4. The same cells were in- 
jected a second time, and this time with a mixture of x-rhodamine 
tubulin to visualize microtubules and caged-fluorescein tubulin 
for analysis of microtubule dynamics by redistribution of fluores- 
cence  after  photoactivation.  Cells were  photoactivated as  de- 
scribed in Materials and Methods. The time course of fluores- 
cence  redistribution  after  photoactivation  was  plotted  as  a 
percentage of fluorescence intensity remaining in the activated 
zones. A, Cells injected with anti-MAP4-C (n =  7, mean -+ SD); 
X, control cells (n =  7, mean _+ SD). 
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by removal of MAP4. Sister cells were used as described in Fig. 5 
with one being injected  (arrows) and one serving as the control 
cell (A and C). LLCMK2 cells were injected with affinity-purified 
anti-MAP4-C  IgG (6 mg/ml) first, and 2 h later treated with no- 
codazole (4 p,g/ml) for 1.5 h to depolymerize all the MTs, includ- 
ing detyrosinated MTs and acetylated MTs (not shown). Then, 
they were washed free of the drug to allow MT regrowth for 1 h. 
Finally, the ceils were lysed, fixed and stained with detyrosinated 
tubulin  antibody (B) and acetylated tubulin  antibodies  (E) re- 
spectively. No obvious differences  in the staining  patterns were 
seen. Bar, 15 p~m. 
To examine the effect of depletion of MAP4 on the level 
of posttranslational modification of MTs, we compared in- 
jected  versus noninjected  ceils stained  with  Abs  against 
detyrosinated or acetylated tubulin. We conducted MT re- 
growth experiments as described previously, because these 
modifications are alterations at the MT polymer level, i.e., 
postpolymerization (Gundersen  et  al.,  1987).  Cells  were 
treated with nocodazole to depolymerize all the detyrosi- 
nated and acetylated MTs (data not shown). Nocodazole 
was then removed, allowing the resultant pool of tubulin 
monomer to polymerize and subsequently gain posttrans- 
lational modifications. MAP4 staining of MTs was absent 
in Ab injected cells throughout this time course. No signif- 
icant  difference in  detyrosinated  or  acetylated MTs was 
seen in injected versus uninjected cells (Fig. 7) suggesting 
that the array of posttranslationally modified MTs was not 
dependent on the presence of MAP4 on MTs. 
Depletion  of  MAP4 on MTs Did Not Prevent 
Mitotic Progression 
To  evaluate  the  dependence  of  spindle  formation  and 
function on MAP4, we examined whether MAP4 could be 
depleted from mitotic spindles as well as from interphase 
MTs. We microinjected MAP4-C Ab into LLCMK2 cells 
in interphase and treated them with a low concentration of 
nocodazole  (0.04  p,g/ml)  in  order  to  accumulate  mitotic 
cells. The cells were released from nocodazole and fixed 
when the majority had progressed to metaphase. As seen 
in Fig. 8 B, MAP4 was not localized on spindles in the in- 
jected  cells;  instead,  large  MAP4-containing  aggregates 
were present. To discern whether a normal mitotic spindle 
could form in cells depleted  of MAP4,  we microinjected 
cells  with  a  mixture  of  rhodamine-labeled  tubulin  and 
anti-MAP4-C and treated them as above using the incor- 
porated  rhodamine-labeled  tubulin  to  visualize  spindle 
formation. As seen in Fig.  8  (D-F),  spindle  morphology 
was  normal  even  though  MAP4  was  not  detectable  on 
spindle MTs. 
To  determine  if  cells  were  capable  of  division  with 
MAP4 depleted from MTs, LLCMK2 cells were injected 
in  interphase  with  anti-MAP4-C  and  followed for 24  h. 
The cells were fixed and stained with rat polyclonal anti- 
bodies against the NH2-terminal portion of MAP4  (anti- 
MAP4-N). Most of the cells divided within one cell cycle. 
Cytokinesis and reconstitution  of the interphase MT net- 
work after division both appeared to be normal; although 
no MAP4 staining was seen on MTs (Fig. 9 B), the MT ar- 
ray reformed normally (Fig. 9 D). Our results suggest that 
MAP4 is not essential for progression through mitosis and 
into G1. 
Microtubule-dependent  IntraceUular Organelle 
Distribution  Was Not Affected by Removal of  MAP4 
from MTs 
Organization  and  cellular positioning of the  Golgi is de- 
pendent upon MTs, as demonstrated by the fragmentation 
of the Golgi in interphase cells with drug-induced disrup- 
tion of MTs. Perturbations of Golgi distribution also occur 
normally when the Golgi fragments at the onset of mitosis 
(Allan and Kreis, 1986). Likewise, mitochondria typically 
coalign with MTs in fibroblasts and their distribution de- 
pends  on  the  integrity  of  the  cytoplasmic MT  network 
(Ball and Singer,  1982).  To test whether MAP4 mediates 
the interaction of MTs and these membranous organelles, 
we performed assays of the distribution of both Golgi and 
mitochondria  in  cells  in  which  MTs  were  depleted  of 
MAP4 by Ab injection. 
We used C6-NBD-ceramide, a  fluorescent lipid deriva- 
tive, to stain the Golgi apparatus (Pagano, 1989)  and the 
fluorescent dye, rhodamine 123, to stain the mitochondria 
of living ceils (Chen,  1989),  that  had  been injected  with 
anti-MAP4-C Ab and incubated for 2 h. As shown in Fig. 
10  (A  and  B),  the  congregation  of the  Golgi apparatus 
around the centrosome was not  altered in  cells in  which 
MAP4  was  depleted  from MTs.  Likewise,  mitochondria 
formed long filaments extending to the tip of the cell pro- 
cess indicating alignment along MTs (Fig. 10, C and D), in- 
dicating there was no perturbation of the  distribution  of 
mitochondria  in  anti-MAP4-C-injected  cells.  Thus,  re- 
moval of MAP4 from microtubules failed to show an ef- 
fect on the distribution  of either of two kinds of cellular 
organelle. 
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and mitosis proceed in the ab- 
sence of MAP4. (A-C) Group 
of four mitotic cells collected 
by treatment with nocodazole 
at low concentration (0.04  I~g/ 
ml) for 14 h. (A) Two cells were 
injected  with  anti-MAP4-C 
IgG  (6  mg/ml)  in  interphase 
(top) and two cells were not in- 
jected (bottom). After removal 
of nocodazole, the  cells were 
allowed to progress for 20 min 
before  being  fixed  and  pro- 
cessed for immunofluorescence. 
Arrows point  to  the  injected 
cells. (B) Immunostaining with 
anti-MAP4-N Ab shows spin- 
dle structures in the uninjected 
cells whereas injected cells  show 
MAP4 immunoprecipitation ag- 
gregates  and  an  absence  of 
spindle staining. (C) Rhodamine 
labeled goat anti-rabbit stain- 
ing confirms the identity of the 
injected cells. (D-F) show a cell 
(arrow) injected with a mixture 
of x-rhodamine-labeled  tubulin 
(0.6  mg/ml) and anti-MAP4-C 
IgG  (0.4  mg/ml)  and  treated 
with nocodazole as for the cells 
in A-C.  (D) Cells stained with 
DAPI to show condensed chromosomes in two cells, left and right; (E) immunostaining with anti-MAP4-N Ab shows no reactivity  in the 
injected cell (left, arrow) but a normal spindle in the uninjected cell (right); (F) direct fluorescence image of x-rhodamine-tubulin incor- 
porated into the spindle of the injected cell confirms that a normal spindle was formed in the absence of MAP4. Bar, 20 Ixm. 
Discussion 
Our  results  demonstrate  that  an  affinity-purified  poly- 
clonal Ab against the MAP4 COOH-terminal region is ef- 
fective in blocking binding of MAP4 to MTs in vitro and in 
vivo. Remarkably, the removal of MAP4 from MTs in vivo 
produced  no  observable phenotype  at  the  cellular level. 
Because of this apparently negative result, it is important 
to  consider  the  efficiency  of  removal  of  MAP4  and 
whether low levels of MAP4 would be sufficient to main- 
tain cellular function. Qualitatively, the absence of MAP4 
staining of mitotic spindles in which MTs are highly con- 
centrated would suggest MAP4 removal was very efficient. 
A  quantitative assessment of the degree of MAP4 removal 
from MTs in vivo was not feasible, since the MAP4 stain- 
ing of ceils is not  reduced  by Ab blocking; instead,  the 
Figure 9.  Cell cycle progression, completion of mitosis and cyto- 
kinesis in the absence of MAP4. Cells were injected with anti- 
MAP4-C antibodies as single cells in interphase and returned to 
culture for 24 h. (A and C) The injected cells have divided into 
two sister cells, identifiable by the residual midbody. (B) Immu- 
nostaining with anti-MAP4-N Ab indicates an immuno-aggregate 
of MAP4 in each sister cell but absence of MAP4 staining of mi- 
crotubules. (D) Antitubulin staining indicates that microtubules 
remained intact. Bar, 20 I.Lm. 
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immuno-depleted cells. (A and B) A  pair of sister  cells, one of 
which was injected with anti-MAP4-C  Ab (arrows); (B) Staining 
with C6-NBD-ceramide for Golgi indicates that the Golgi appara- 
tus remains compact and in the perinuclear area in injected  as 
well as uninjected cells. (C and D) Cell injected with anti-MAP4-C 
Ab. (D) Staining with rhodamine 123 for visualization  of mito- 
chondria in the living cell indicates that mitochondria remain dis- 
persed throughout the cytoplasm in injected as well as uninjected 
cells. Bar, 15 txm. 
staining is relocated from MTs to MAP4-Ab aggregates. 
Although our blocking assay conditions in vitro may not 
be exactly comparable to the in vivo situation, the levels of 
blocking observed in vitro provide a  reasonable estimate 
of  the  range  of  blocking  efficiency  achievable  by  anti- 
MAP4-C  microinjection.  In  vitro,  MAP4  removal  was 
85%  at a  concentration of 0.06 mg/ml Ab (equivalent to 
injection of 1% of the cell volume with Ab at a needle con- 
centration  of 6  mg/ml) to 98%  at a  concentration  of 0.6 
mg/ml (equivalent to injection of 10% of the cell volume 
with  6  mg/ml Ab).  The  mass  ratio  of MAP4  to  tubulin 
monomer in Hela cell extracts was previously estimated as 
1% (Bulinski and Borisy, 1980a). Assuming 2/3 of tubulin 
is  in  the  form  of polymer (Zhai  and  Borisy,  1994)  and 
greater than 90% of MAP4 is bound to MTs (Bulinski and 
Borisy, 1980a)  and given the molecular weight for MAP4 
of 125,000  and for tubulin monomer of 50,000,  this corre- 
sponds to a molar ratio of MAP4 to tubulin monomer on 
the microtubule of 1:185. If blocking was 85-98% efficient 
in vivo, the remaining MAP4 would be at a 1:1,240-1:9,250 
ratio to tubulin monomer. Given that the MT lattice con- 
tains 3,650  tubulin monomers per ~m length,  this would 
mean the residual MAP4 would be at a level of less than 
one to three molecules per Ixm. This level would likely be 
below  detection  limits  by  conventional  immunofluores- 
ence. We cannot exclude the possibility that such a  small 
amount of remaining MAP4 might be enough to maintain 
its functions; however, were such a small amount to be suf- 
ficient, it would mean that the cell normally produces a 
7-50-fold surplus of MAP4, a biologically improbable con- 
dition. 
A  previous investigation using a monoclonal Ab against 
only the third assembly promoting repeat of MAP2 found 
no  inhibition  of  MAP  binding  to  MTs  (Dingus  et  al., 
1991).  Instead the  Ab bound  to the  MAPs  and  co-sedi- 
mented with MTs.  Our polyclonal antiserum,  which  was 
raised  against a  COOH-terminal domain of MAP4,  pre- 
sumably contains a  number of different antibody species 
whose epitopes span the MT-binding region. This allows 
for two blocking mechanisms which are not possible with a 
monoclonal IgG directed against a  single epitope: (a) Ab 
binding to multiple MAP epitopes in the MT-binding re- 
gion producing steric inhibition of binding;  (b) formation 
of  Ab-MAP  immunoprecipitates  which  irreversibly  se- 
quester MAPs.  Both the  ability to sediment the MAP4- 
Ab complexes in our in vitro assay and the formation of 
MAP4  containing  aggregates in  the  anti-MAP4--injected 
cells would suggest that removal of MAP4 from MTs is ul- 
timately a  result  of its  sequestration  in  immunoprecipi- 
tares. Initially, the Abs could either interact with epitopes 
at the MT binding site and thus displace MAP4 and/or in- 
teract with MAP4 in the soluble pool and prevent its re- 
binding to MTs. Because MAP4 binding to MTs was de- 
termined  to  be  in  rapid  equilibrium  with  a  half  life  of 
about 44 s in interphase cells (Olmsted et al., 1989), bind- 
ing of Ab to MAP4 molecules in the soluble pool would be 
expected  to  drive  the  equilibrium  away  from  the  MT- 
bound state, thus depleting the MTs of MAP4. 
Immunoprecipitation of cytoskeletal proteins within live 
cells following microinjection  of specific polyclonal Abs 
has been observed previously for nonerythrocyte spectrin 
(Mangeat  et  al.,  1984),  ct-actinin  (Jockusch,  1991),  and 
talin (Nuckolls et al., 1992). Cells in which the antigen has 
been quantitatively precipitated (as assessed by immuno- 
fluorescence) have been characterized as "phenotypically 
equivalent to mutants defective in their (cytoskeletal pro- 
tein)" (Mangeat et al., 1984). 
Injection of anti-MAP4-C into cells effectively removed 
MAP4 from MTs,  constituting  an in  vivo immunodeple- 
tion experiment. Yet, unexpectedly, no effect on MT sta- 
bility or assembly was observed. The ability of MAPs, in- 
cluding  MAP4  to promote MT  assembly and  affect MT 
dynamics is well characterized in  vitro (reviewed by Hi- 
rokawa, 1994). Based on these in vitro studies, it was rea- 
sonable to expect that MTs depleted of MAP4 would ex- 
hibit  abnormalities.  However,  a  review  of  attempts  to 
modulate  MAP  levels  in  vivo indicates  that  the  results 
available to date are enigmatic. On one hand, a number of 
studies have demonstrated that MT stability and increased 
tubulin assembly correlate with the introduction of exoge- 
nous MAPs. Injection of tau protein, at a  level predicted 
to be sufficient to saturate its MT-binding sites, led  to a 
44% increase in MT polymer as well as resistance of MTs 
to depolymerization by nocodazole  (Drubin  and  Kirsch- 
ner, 1986). Transfection of nonneuronal cells with the neu- 
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pression,  resulted  in  the  formation  of MT bundles  with 
greatly enhanced stability (Lewis et al., 1989; Kanai et al., 
1992;  Lee and Rook, 1992).  On the other hand, injection 
of fluorescein-derivatized MAP2  or MAP4  at concentra- 
tions comparable to endogenous levels produced  no dis- 
cernible difference in the amount of MT polymer or MT 
stability (Vandenbunder and Borisy, 1986;  Olmsted et al., 
1989). In a recent report, Barlow et al. (1994) did not ob- 
serve a significant effect on MT polymer level or drug sta- 
bility in stable CHO cell transfectants that expressed high 
levels of MAP4 or tau. 
Investigations designed to elucidate MAP functions by 
reduction of MAP expression have similarly yielded simi- 
larly  mixed  results.  Lowering  tau  expression  with  anti- 
sense oligonucleotides indicated that tau was required for 
the development of MT-containing axon-like processes in 
cultured cerebellar cells (Caceres and Kosik, 1990).  MAP2 
antisense  constructs  were  used  to  inhibit  MAP2  expres- 
sion  and  showed  that  cells  induced  to  differentiate  into 
neurons lacking MAP2 cannot extend neurites (Dinsmore 
and  Solomon,  1991).  These studies  suggested  that  MAP 
expression  may be  essential  in  producing  the  increased 
level of highly stabilized MTs characteristic of mature neu- 
rons. However, targeted mutation of the tau gene to pro- 
duce  mice that  lacked  tau  expression resulted  in  only a 
subtle structural alteration in one type of cerebellar axon, 
and  the  mice  suffered  no functional  consequences.  Fur- 
ther, Drosophila bearing a homozygous deficiency for the 
205-kD MAP gene were fully viable and showed no obvi- 
ous phenotype  (Pereira et  al.,  1992).  These different re- 
suits leave open the question of MAP function in cells and 
in animals. 
Both overexpression and deletion experiments have in- 
trinsic limitations. A  general problem for overexpression 
studies is their relevance to function at normal levels. Arti- 
facts of mislocalization, artifacts due to occupancy of low 
affinity binding sites, or in the case of MAPs, MT bundle 
formation may occur. On the other side, overexpression of 
a  MAP  might  yield  no  phenotype  if either  the  overex- 
pressed protein or MT dynamic parameters are regulated 
to  resist  changes  which  might  result  from increased  ex- 
pression.  Deletion  experiments in  whole  organisms may 
also  be  hard  to  interpret  because  other  proteins  might 
overlap the function of the deleted protein. For example, 
the mice in which tau was knocked out showed higher lev- 
els of MAP1A (Harada et al., 1994); perhaps their level of 
MAP4  (which  was  not  assayed)  was  also  changed.  Al- 
though compensatory mechanisms may exist at either the 
organismal or cellular levels, we consider that studies di- 
rected at the cellular level often provide a more direct way 
of assaying cellular function. Further, higher resolution as- 
says are available at the cellular level, since single fibers 
and organelles can be resolved and MT dynamics can be 
accurately measured. Finally, studies in which a protein is 
removed or knocked out seem more direct than those in 
which it is overexpressed. If an expected phenotype is not 
obtained, perhaps a more subtle but nevertheless biologi- 
cally significant effect may still be identified. It is from this 
perspective  that  we  attempted  to  assay a  range  of MT- 
related functions in MAP4-depleted cells. 
One possibility is that a  subset of MTs are particularly 
affected by MAP4 depletion even if the bulk population is 
not. It has been shown that acetylated MTs, which corre- 
late  with  stable  MTs,  increased  dramatically  upon  tau 
transfection  (Lee and Rock,  1992).  Therefore, we tested 
whether MAP4 is required for acquiring posttranslational 
modifications of MTs.  However, our results showed that 
the level of posttranslational modifications of MTs was ap- 
parently not reduced by removing MAP4 from MTs in the 
cell.  In  normal  proliferating  ceils  a  small  population  of 
MAP4-depleted MTs has been demonstrated (Chapin and 
Bulinski, 1994).  Analogous to the MAP4-depleted MTs in 
Ab-injected cells, the naturally occuring MAP4-depleted 
MTs are apparently not different in stability or function 
from MAP4-containing MTs in the same cells. 
An important potential function of MAP4, its role in mi- 
tosis, was also evaluated in our experiments. At the onset 
of mitosis, assembly of the mitotic spindle occurs after dis- 
solution  of the interphase  network of MTs and requires 
highly  dynamic MTs  (Belmont  et al.,  1990).  It has been 
shown that the activity of MPF is sufficient to increase MT 
dynamics at the onset of mitosis (Verde et al., 1990). Thus, 
the interphase-mitosis transition of MT dynamics is thought 
to be induced  by phosphorylation reactions mediated by 
MPF,  and  by  MAP  kinase  functioning  downstream  of 
MPF (Shiina et al., 1992).  However, the in vivo substrates 
of the kinases that are involved in the regulation of MT 
dynamics have not been identified. One view is that phos- 
phorylation of MAPs alters their ability to stabilize MTs at 
the  interphase  to  mitosis  transition.  In  fact  MAP4  be- 
comes  highly  phosphorylated  in  mitosis  (Vandr6  et  al., 
1991)  and  phosphorylation  of MAP4  by cdc2  kinase  in 
vitro reduces its MT assembly-promoting and -stabilizing 
activities (Aizawa et al., 1991; Ookata et al., 1995). 
Izant et al. (1983) showed that a monoclonal Ab, which 
presumably bound to HeLa MAP4, when injected into mi- 
totic  PtK1  cells  before  the  onset  of anaphase  inhibited 
karyokinesis. Although the Ab stained PtK1  spindles, no 
PtK1 antigen was identified. Therefore, the observed inhi- 
bition could have been a result of the Ab acting on an anti- 
genic deterninant shared with MAP4 by another as yet un- 
identified  protein.  Furthermore,  unlike  our  polyclonal 
anti-MAP4,  the  injected  monoclonal  Ab  bound  to  the 
spindle rather than removing the antigen from the spindle. 
Thus, this mitotic inhibition was the result of an uncharac- 
terized process distinct from the removal of MAP4 that we 
observe.  In  our  experiments,  we  tested  whether  MAP4 
was essential for mitosis by using antibody to deplete  it 
from MTs. The result was that the spindle formed and the 
cells divided even though MAP4 was effectively removed 
from the spindle; thus, mitotic progression was not depen- 
dent on the continued presence of MAP4 on MTs. Never- 
theless, in this experiment, we did not address the question 
of whether or not the phosphorylation of MAP4 by cdc2 
kinase plays an active role in mitosis. To test this possibil- 
ity directly, the phosphorylation sites need to be mapped 
and mutagenized in such a way as to prevent MAP4 from 
being phosphorylated. 
Additional MT-related functions assayed were possible 
involvements  in  organelle  transport.  The  proteins  that 
bind to MTs may be divided into  two categories: motor 
proteins and structural components capable of stabilizing 
MTs. Whereas MAP4 and the other MAPs have been con- 
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ular motors of the  dynein  and  kinesin  superfamilies  are 
members of the motor class. Furthermore, a novel class of 
CLIPs has been identified that mediates the interaction of 
cytoplasmic  organelles  with  microtubutes  (Pierre  et  al., 
1992,  1994).  We  assayed  for  possible  effects  MAP4  re- 
moval might  have  on the  MT-dependent  distribution  of 
organelles. The presence of MAP4 might be expected  to 
affect interactions of organelles with MT motor proteins; 
however, no effects were seen on the distribution  of or- 
ganelles known to interact with either plus end- or minus 
end-directed motors. 
Since MAP4 is ubiquitous in proliferating cells, it is hard 
to believe that it does not have any function. MAP4 may 
play some role which is beyond our assays. For example, 
MAP4 may affect the stiffness or spacing of MTs such as 
has been suggested for MAP2 (Matus, 1994). Although we 
did not detect any gross alterations of microtubule shape 
or arrangement in the absence of MAP4,  more subtle ef- 
fects on integrative phenomena such as persistence of di- 
rectional locomotion or polarity of cell form cannot be ex- 
cluded.  MAP4  may  function  at  certain  developmental 
stages  in  specific  organs  or  tissues,  and  be  merely  ex- 
pressed gratuitously in cell culture. To test this possibility, 
transgenic knock-out of the MAP4 gene will be required. 
Alternatively, some functional redundancy might exist be- 
tween MAP4 and other MT-associated proteins that play a 
role in regulating microtubule stability and function. The 
synthetic lethal approach in cell biology has revealed nu- 
merous examples of redundant gene function including as- 
pects of cytoskeletal function (Welch et al., 1994). An ad- 
ditional MAP of 125 kD, named ensconsin (Bulinski and 
Bossier,  1994),  has  recently been characterized although 
its role in microtubule function has yet to be determined. 
Unlike  MAP4,  which rapidly  dissociates from MTs  after 
the detergent lysis needed  to prepare a cytoskeleton, en- 
sconsin  remains  bound.  Evidence  of  another  dilution- 
insensitive regulatory factor for microtubule stability in fi- 
broblasts has recently been provided (Lieuvin et al., 1994). 
Possibly, these or other factors serve a function compensa- 
tory or partially redundant with MAP4. Further knock-out 
or deletion experiments will be required to resolve these 
issues. 
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